AAP
MYOV

Ardsley Advisory Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

Ardsley Advisory Partners’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,100
Closed -$142K – 205
2020
Q3 		$142K Sell
10,100
-9,900
-50% -$184K 0.03% 133
2020
Q2 		$412K Buy
+20,000
New +$272K 0.09% 91
2018
Q1 		– Sell
-100,000
Closed -$1.27M – 182
2017
Q4 		$1.27M Buy
+100,000
New +$1.34M 0.15% 66

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Ardsley Advisory Partners's MYOV Position: Q4 2020 in Review

Ardsley Advisory Partners sold out of Myovant Sciences Ltd. (MYOV) in Q4 2020, closing a stake of 10,100 shares — an estimated $142K sold.

Ardsley Advisory Partners first reported a position in MYOV in Q4 2017 and held it in 3 quarters. The position peaked at $1.27M in Q4 2017. 105 funds tracked by Wall St. Rank hold MYOV as of Q4 2020.

  • Ardsley Advisory Partners reported no remaining Myovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • Ardsley Advisory Partners sold 10,100 Myovant Sciences Ltd. shares in Q4 2020, an estimated $142K.
  • Ardsley Advisory Partners first reported a position in Myovant Sciences Ltd. in Q4 2017 and held it in 3 quarters.
  • Ardsley Advisory Partners's Myovant Sciences Ltd. position peaked at $1.27M in Q4 2017.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2020.

Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.